Philips and Masimo Renew and Expand Patient Monitoring Partnership

Philips and Masimo have announced a renewed multi-year strategic collaboration, focusing on the integration of patient monitoring technologies and the development of new tools, including artificial intelligence algorithms. This partnership extension comes as both companies aim to improve patient care through advanced monitoring solutions.

Expanded Integration of Masimo Technologies

The renewed agreement will accelerate the integration of Masimo's SET pulse oximetry technology into Philips' multi-parameter patient monitors through 2026 and beyond. This technology, which tracks oxygen saturation and pulse rate, will be complemented by other Masimo innovations, including:

• Continuous hemoglobin monitoring
• Brain function assessment tools
• Carbon dioxide exhalation tracking
• Advanced O3 regional oximetry, recently cleared by the FDA

As part of the expanded partnership, Philips will expedite the adoption of these technologies across additional devices and market segments, broadening their reach in healthcare settings.

Next-Generation Wearables and AI Development

A key focus of the renewed collaboration is the integration of Masimo's Radius PPG wireless, wearable sensor technology with Philips' bedside monitors and next-generation wearable multi-parameter devices. This initiative aims to enhance patient mobility while maintaining continuous monitoring capabilities.

The partnership will also emphasize the co-development and promotion of artificial intelligence-powered solutions. While specific details of these AI projects were not disclosed, both companies expressed enthusiasm about leveraging AI to advance patient care.

Commercial Expansion and Market Strategy

Julia Strandberg, Philips' business leader for connected care, highlighted the partnership's role in responding quickly to evolving clinical needs and market trends. The collaboration is expected to result in solutions that are not only technologically advanced but also user-friendly, reliable, and scalable.

Masimo CEO Katie Szyman emphasized the importance of expanding their long-standing partnership with Philips, stating that it would ensure Masimo's technologies reach a broader patient base. This renewal also addresses recent market speculations about Masimo's relationship with Philips, particularly in light of Philips' separate partnership renewal with Medtronic in July 2025.

The companies' joint efforts will extend beyond hospital settings, with plans to integrate Masimo's W1 smartwatch into Philips' patient monitoring platforms for post-discharge care. This move signifies a growing trend towards continuous patient monitoring across the care continuum.